Shopping Cart 0
Cart Subtotal
USD 0

Aragen Bioscience Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc, is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process development and production, primary and immortalized cell-based assays, in vivo models of human disease and custom immunological services. Its cell line development services include molecular biology and cell culture, cell line productivity and stability studies, cell culture, and analytical services. Aragen offers in vitro and in vivo efficacy testing that provides treatment in the therapeutic areas of fibrosis, infectious disease, oncology, immunology and others. The company serves biotech and pharmaceutical industries .Aragen is headquartered in Morgan Hill, California, the US.

Aragen Bioscience Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aragen Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 9

Venture Financing 9

Aragen Bioscience Raises USD 2.7 Million In Venture Financing 9

Partnerships 10

Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 10

Licensing Agreements 11

Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 11

Acquisition 12

GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 12

Aragen Bioscience Inc-Key Competitors 13

Aragen Bioscience Inc-Key Employees 14

Aragen Bioscience Inc-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Legal and Regulatory 16

Mar 22, 2018: Kyowa Hakko Kirin and BioWa Obtain Successful Settlement of United States Patent Infringement Lawsuit against Aragen Bioscience and Transposagen 16

Appendix 17

Methodology 17

About GlobalData 17

Contact Us 17

Disclaimer 17


List Of Figure

List of Figures

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7


List Of Table

List of Tables

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aragen Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

Aragen Bioscience Raises USD 2.7 Million In Venture Financing 9

Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 10

Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 11

GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 12

Aragen Bioscience Inc, Key Competitors 13

Aragen Bioscience Inc, Key Employees 14

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc, is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process development and production, primary and immortalized cell-based assays, in vivo models of human disease and custom immunological services. Its cell line development services include molecular biology and cell culture, cell line productivity and stability studies, cell culture, and analytical services. Aragen offers in vitro and in vivo efficacy testing that provides treatment in the therapeutic areas of fibrosis, infectious disease, oncology, immunology and others. The company serves biotech and pharmaceutical industries .Aragen is headquartered in Morgan Hill, California, the US.

Aragen Bioscience Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aragen Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 9

Venture Financing 9

Aragen Bioscience Raises USD 2.7 Million In Venture Financing 9

Partnerships 10

Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 10

Licensing Agreements 11

Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 11

Acquisition 12

GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 12

Aragen Bioscience Inc-Key Competitors 13

Aragen Bioscience Inc-Key Employees 14

Aragen Bioscience Inc-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Legal and Regulatory 16

Mar 22, 2018: Kyowa Hakko Kirin and BioWa Obtain Successful Settlement of United States Patent Infringement Lawsuit against Aragen Bioscience and Transposagen 16

Appendix 17

Methodology 17

About GlobalData 17

Contact Us 17

Disclaimer 17


List Of Figure

List of Figures

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7


List Of Table

List of Tables

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aragen Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aragen Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

Aragen Bioscience Raises USD 2.7 Million In Venture Financing 9

Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 10

Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 11

GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 12

Aragen Bioscience Inc, Key Competitors 13

Aragen Bioscience Inc, Key Employees 14

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS